Dividendos de Malaysian Genomics Resource Centre Berhad

Dividendo controles de criterios 0/6

Malaysian Genomics Resource Centre Berhad no paga actualmente dividendo.

Información clave

Rentabilidad por dividendo

Ratio de pago

Rentabilidad media de la industria	1.2%
Próxima fecha de pago de dividendos	n/a
Fecha ex dividendo	n/a
Dividendo por acción	n/a
Beneficios por acción	-RM0.14
Rentabilidad por dividendo prevista a 3 años	n/a

Últimas actualizaciones de dividendos

No hay actualizaciones

Recent updates

Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)?

Mar 02

We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth

Feb 15

Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth

Nov 02

Estabilidad y crecimiento de los pagos

Obteniendo datos sobre dividendos

Dividendo estable: No hay datos suficientes para determinar si los dividendos por acción de MGRC han sido estables en el pasado.

Dividendo creciente: Datos insuficientes para determinar si los pagos de dividendos de MGRC han aumentado.

Rentabilidad por dividendo vs. Mercado

Rentabilidad por dividendo de Malaysian Genomics Resource Centre Berhad vs. Mercado

¿Cómo se compara la rentabilidad por dividendo de MGRC con la del mercado?
Segmento	Rentabilidad por dividendo
Empresa (MGRC)	0%
Suelo de mercado 25% (MY)	1.8%
Techo de mercado 25% (MY)	4.5%
Media de la industria (Life Sciences)	1.2%
Previsión de analistas en 3 años (MGRC)	n/a

Dividendo destacado: No es posible evaluar la rentabilidad por dividendo de MGRC en comparación con el 25% inferior de los pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Alto dividendo: No es posible evaluar la rentabilidad por dividendo de MGRC en comparación con el 25% de los principales pagadores de dividendos, ya que la empresa no ha comunicado ningún pago reciente.

Pago de beneficios a los accionistas

Cobertura de los beneficios: MGRC no paga un dividendo notable para el mercado MY.

Pago en efectivo a los accionistas

Cobertura de flujo de caja: No es posible calcular la sostenibilidad de los dividendos, ya que MGRC no ha comunicado ningún pago.

Dividendos de Malaysian Genomics Resource Centre Berhad

Dividendo controles de criterios 0/6

Información clave

Últimas actualizaciones de dividendos

Recent updates

New major risk - Revenue and earnings growth

Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024

Malaysian Genomics Resource Centre Berhad, Annual General Meeting, Apr 29, 2024

Malaysian Genomics Resource Centre Berhad Announces Redesignation of Encik Muhammad Badri Bin Hussin to Chief Operating Officer from Director

Full year 2023 earnings: EPS and revenues miss analyst expectations

Malaysian Genomics Resource Centre Berhad Announces Update on Material Litigation

Malaysian Genomics Resource Centre Berhad Appoints Mohammad Hasni Bin Ibrahim as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Appoints Datuk Wira Muhammad Faizal Bin Zainol as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Aswath A/L Ramakrishnan as A Non-Audit and Risk Management Committee Member

Malaysian Genomics Resource Centre Berhad Provides Material Litigation Update

Malaysian Genomics Resource Centre Berhad Appoints Encik Muhammad Badri Bin Hussin, Age 50, as Member of Audit Committee, Date of Change 25 Oct 2023

Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Muhammad Badri Bin Hussin as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Appointment of Encik Mohamad Ruzaini Bin Hamzah as Independent and Non Executive Director

Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Sasha Omar Firdaus Bin Aamir Nordin as Chief Executive Officer

Full year 2023 earnings released: RM0.11 loss per share (vs RM0.059 profit in FY 2022)

Malaysian Genomics Resource Centre Berhad Announces Resignation of Aswath A/L Ramakrishnan as Independent and Non Executive Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Appoints Miss Chih Yi May as Independent and Non Executive Director effective June 1, 2023

High number of new and inexperienced directors

Consensus revenue estimates fall by 33%

Malaysian Genomics Resource Centre Berhad Appoints Encik Syed Zulkifli Bin Syed Ismail as Independent and Non Executive Member of Nomination and Remuneration Committee

Third quarter 2023 earnings released: RM0.022 loss per share (vs RM0.016 profit in 3Q 2022)

Malaysian Genomics Resource Centre Berhad Re-designates Encik Mohd Shakir Bin Shahimi to Chairman of Audit Committee

Malaysian Genomics Resource Centre Berhad Appoints Mr. Aswath A/L Ramakrishnan as Independent and Non Executive Director

Is Now An Opportune Moment To Examine Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)?

Price target decreased by 13% to RM0.95

Second quarter 2023 earnings released: RM0.01 loss per share (vs RM0.008 profit in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0.007 (vs RM0.002 in 1Q 2022)

Malaysian Genomics Resource Centre Berhad Announces the Re-Designation of Encik Mohd Shakir Bin Shahimi from Member of Nomination and Remuneration Committee to Chairman of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Announces Resignation of Teoh Ai Ling as Principal Officer

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021)

High number of new and inexperienced directors

Full year 2022 earnings released: EPS: RM0.059 (vs RM0.04 loss in FY 2021)

Malaysian Genomics Resource Centre Berhad Appoints Encik Mohd Shakir Bin Shahimi as Member of Nomination and Remuneration Committee

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad announces redesignation of Dato' Seri Dr. Chen Chaw Min from Independent Director to Independent and Non Executive Chairman

Others Malaysian Genomics Announces Board Changes

Malaysian Genomics Resource Centre Berhad Appoints Ku Chong Hong, Designation Chairman of Nomination and Remuneration Committee Directorate Independent and Non Executive, Date of Change 13 Jul 2022

Third quarter 2022 earnings released: EPS: RM0.016 (vs RM0.002 in 3Q 2021)

High number of new and inexperienced directors

Malaysian Genomics Resource Centre Berhad Announces the Launch of Its Genetic Screening Plus Personalised Health Supplements Solutions on the Airasia Super App

Second quarter 2022 earnings: EPS in line with expectations, revenues disappoint

Malaysian Genomics Resource Centre Berhad Announces Re-Designation of Encik Noor Azri Bin Dato' Sri Noor Azerai as Independent Executive Director

We Think Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Can Afford To Drive Business Growth

High number of new and inexperienced directors

First quarter 2022 earnings: EPS in line with expectations, revenues disappoint

High number of new directors

Financial Controller Sek Cheah has left the company

Senior Independent Non-Executive Chairman Rafiah Salim has left the company

Companies Like Malaysian Genomics Resource Centre Berhad (KLSE:MGRC) Are In A Position To Invest In Growth

Full year 2021 earnings released: RM0.04 loss per share (vs RM0.062 loss in FY 2020)

High number of new directors

New 90-day high: RM1.22

New 90-day high: RM1.18

New 90-day high: RM1.11

New 90-day high: RM0.80

Malaysian Genomics Resource Centre Berhad Renames the Audit Committee as Audit and Risk Management Committee

First quarter 2021 earnings released: RM0.008 loss per share

New 90-day high: RM0.64

Malaysian Genomics Resource Centre Berhad Announces Appointment of ENCIK SASHA OMAR FIRDAUS BIN AAMIR NORDIN as Chief Executive Officer

New 90-day high - RM0.53

Malaysian Genomics Resource Centre Berhad Announces Resignation of Encik Robert George Hercus @ Abdul Karim Hercus as Executive Managing Director

Estabilidad y crecimiento de los pagos

Rentabilidad por dividendo vs. Mercado

Pago de beneficios a los accionistas

Pago en efectivo a los accionistas

Discover strong dividend paying companies